ACTIVE

Groupement Radiothérapie Hématologie Oncologie

Financial year 2025 · Closed on 31/12/2025

Net result-248,2 k €-768,1 %over 1 year

Gross margin-237,1 k €-1 128,0 %over 1 year

Equity1,4 M €-15,5 %over 1 year

Identity

Source · BCE/KBO

Groupement Radiothérapie Hématologie Oncologie is a Non-profit organization incorporated in 1994. Its registered office is in Bruxelles.

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0452.611.502
Incorporation: 17/03/1994
Legal form: Non-profit organization
Registered office: Boulevard du Jardin Botanique 32
1000 Bruxelles · BruxellesSee on map
Latest accounts: 31/12/2025

Signals

Solid equityLow riskGood liquidity

Financials

Source · NBB, 9 filings

Trend over 9 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	-237,1 k €	-1128%	-19,3 k €	+91.2%	-218,3 k €	-141%	-90,7 k €	-416%	28,7 k €
EBITDA	-238,8 k €	-1084%	-20,2 k €	+90.8%	-218,7 k €	-140%	-91,3 k €	-435%	27,2 k €
Operating result	-249 k €	-724%	-30,2 k €	+86.8%	-228,8 k €	-147%	-92,6 k €	-459%	25,8 k €
Net result	-248,2 k €	-768%	-28,6 k €	+87.5%	-229,3 k €	-146%	-93,2 k €	-467%	25,4 k €
Balance sheet
Equity	1,4 M €	-15.5%	1,6 M €	-1.8%	1,6 M €	-12.3%	1,9 M €	-4.8%	2 M €
Total assets	1,4 M €	-14.1%	1,6 M €	-2.2%	1,6 M €	-11.9%	1,9 M €	-4.8%	2 M €
Cash	804,2 k €	-12.8%	922 k €	+21.1%	761,2 k €	-21.3%	966,6 k €	-1.5%	981,1 k €
Debts	2,8 k €	+434%	521,8 €	-93.1%	7,6 k €	+6649%	112,2 €	-83.2%	666,2 €

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 1 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Deborah BAUWENS	Directorsince 01/01/2018
Sabine MARICHAL	DirectorSecrétaire01/01/2018 → 31/12/2023endedMandateended
Sophie CVILIC	DirectorMandate01/01/2018 → 31/12/2023ended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Adinda BATEN	Director01/01/2018 → 31/12/2023

Other companies at this address

Boulevard du Jardin Botanique 32 1000 Bruxelles

Company	CBE no.
BRUSSELS HEART CENTER● Active	0899.026.484
CEBIODI● Active	0476.058.479
CHPL SAINT-JEAN● Active	0818.754.135
Clinique Saint-Jean● Active	0409.890.128
DOCTEUR HUGUES FIERENS● Active	0865.541.490
DOCTEUR REZA CHAMLOU● Active	0817.904.691
Fondation Saint - Jean - Sint - Jan Stichting● Active	0447.245.323
GHO ST JEAN● Active	0673.513.461
Nefrologie Kliniek Sint-Jan Brussel● Active	1022.688.024
NEURO SAINT - JEAN● Active	0432.094.220
OB - GYN ST. JEAN● Active	0440.192.730
ORMP association de frais● Active	0674.629.654
PALIATIEVE ZORGEN SINT JAN - SOINS PALLIATIFS SAINT JEAN● Active	0438.303.012
PEDIATRIE SJ● Active	0822.756.077
SERVICE D'ANESTHESIOLOGIE● Active	0433.944.247
SERVICE DE CHIRURGIE GENERALE SAINT JEAN● Active	1011.223.614
Service ORL Clinique Saint-Jean● Active	0843.236.044
The European Board of Cardiovascular Perfusion● Active	0696.823.650
Urologie Sint Jan Brussel● Active	0704.867.227
UTVA DU GROUPE SERVICE DE CHIRUGIE GENERAL ET THORACIQUE - SAINT-JEAN● Active	0658.723.733

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	22/07/2026	11/08/2025	05/07/2024	06/07/2023	14/07/2022	30/08/2021
General meeting	29/06/2026	30/06/2025	28/06/2024	30/06/2023	30/06/2022	30/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 9 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	29/06/2026	22/07/2026	French	PDF
Abridged model	31/12/2024	30/06/2025	11/08/2025	French	PDF
Abridged model	31/12/2023	28/06/2024	05/07/2024	French	PDF
Abridged model	31/12/2022	30/06/2023	06/07/2023	French	PDF
Abridged model	31/12/2021	30/06/2022	14/07/2022	French	PDF
Abridged model	31/12/2020	30/06/2021	30/08/2021	French	PDF
Abridged model	31/12/2019	30/09/2020	29/10/2020	French	PDF
Abridged model	31/12/2018	27/06/2019	17/07/2019	French	PDF
Abridged model	31/12/2017	25/06/2018	19/07/2018	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 1 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Deborah BAUWENS	Directorsince 01/01/2018
Sabine MARICHAL	DirectorSecrétaire01/01/2018 → 31/12/2023endedMandateended
Sophie CVILIC	DirectorMandate01/01/2018 → 31/12/2023ended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Adinda BATEN	Director01/01/2018 → 31/12/2023

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates04/08/2025
DEMISSIONS, NOMINATIONS
PDF
Other26/02/2024
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates10/07/2019
DEMISSIONS, NOMINATIONS
PDF
Mandates27/07/2018
DEMISSIONS, NOMINATIONS
PDF
Mandates23/07/2012
DEMISSIONS, NOMINATIONS
PDF
Mandates28/06/2011
DEMISSIONS, NOMINATIONS
PDF
Mandates06/04/2011
DEMISSIONS, NOMINATIONS
PDF
Mandates07/05/2010
DEMISSIONS, NOMINATIONS
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings9 filings

Mandates

Adinda BATEN

Sabine MARICHAL

Deborah BAUWENS

Sophie CVILIC

199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026

Groupement Radiothérapie Hématologie Oncologie

Boulevard du Jardin Botanique 32, 1000 Brussels

Director

Secrétaire

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Boulevard du Jardin Botanique 32, 1000 BrusselsCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00323563

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
Groupement Radiothérapie Hématologie OncologieCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00323563

Events

2025
Annual accounts 2025-248,2 k €↓
2024
Annual accounts 2024-28,6 k €↑
2023
Annual accounts 2023-229,3 k €↓
2022
Annual accounts 2022-93,2 k €↓
2021
Annual accounts 202125,4 k €↑
2020
Annual accounts 2020-23,6 k €↓
2019
Annual accounts 2019235,6 k €↑
2018
Annual accounts 201860,2 k €↓
2017
Annual accounts 2017296,9 k €
17/03/1994
IncorporationNon-profit organization

Groupement Radiothérapie Hématologie Oncologie

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events